Oncologix Tech, Inc announced that it has received $0.02 million in funding.
On October 16, 2012, Oncologix Tech, Inc closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -50.00% | -96.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-96.00% | 166K | |
+125.89% | 7.23B | |
+2.38% | 984M | |
+41.91% | 883M | |
+16.19% | 764M | |
+2.11% | 667M | |
+1.44% | 642M | |
-.--% | 600M | |
+8.61% | 536M | |
-.--% | 500M |